Division of Sleep Medicine, Harvard Medical School, Sleep Health Centers, Brigham and Women's Hospital, 1505 Commonwealth Avenue, 5th Floor, Brighton, MA 02135, USA.
Neurol Clin. 2012 Nov;30(4):1045-66. doi: 10.1016/j.ncl.2012.08.012.
Insomnia is a common disorder, with individual and societal consequences. Advances have been made in the understanding of insomnia and its treatment options. However, cognitive behavioral therapy and Food and Drug Administration-approved pharmacologic therapies have limitations, the former primarily involving access and the latter involving potential side effects. Further research is needed to optimize management strategies.
失眠是一种常见的疾病，会对个人和社会造成影响。人们对失眠及其治疗选择的认识已经取得了进展。然而，认知行为疗法和美国食品和药物管理局批准的药物治疗存在局限性，前者主要涉及可及性，后者则涉及潜在的副作用。需要进一步研究以优化管理策略。
